Yoshihiro Matsumoto Selected Research

5-hydroxymethyl-2'-deoxyuridine

1/2015

Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Matsumoto Research Topics

Disease

49	Neoplasms (Cancer) 09/2022 - 01/2003
15	Sarcoma (Soft Tissue Sarcoma) 06/2022 - 01/2017
9	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 03/2002
6	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2005
6	Fibrosis (Cirrhosis) 01/2021 - 03/2002
5	Pain (Aches) 11/2021 - 06/2014
4	Infections 04/2022 - 01/2016
4	Inflammation (Inflammations) 01/2021 - 06/2003
4	Neurofibrosarcoma (MPNST) 01/2021 - 01/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 01/2015
4	Arthritis (Polyarthritis) 11/2017 - 06/2002
4	Bone Resorption 11/2016 - 06/2003
4	Hypersensitivity (Allergy) 01/2016 - 02/2010
3	Synovial Sarcoma (Synovioma) 01/2022 - 01/2017
3	Carcinoma (Carcinomatosis) 01/2022 - 11/2004
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
3	Fibroma (Fibromatosis) 11/2021 - 01/2019
3	Aggressive Fibromatosis (Desmoid) 11/2021 - 01/2019
3	Wounds and Injuries (Trauma) 08/2021 - 08/2011
3	Adenocarcinoma 03/2021 - 11/2004
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 05/2012
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 03/2020
3	Margins of Excision 11/2019 - 03/2018
3	Chronic Hepatitis C 02/2019 - 03/2002
3	Testicular Neoplasms (Testicular Cancer) 01/2018 - 03/2010
3	Leiomyosarcoma 01/2018 - 06/2012
3	Spinal Cord Diseases 01/2018 - 04/2012
3	Overactive Urinary Bladder (Overactive Bladder) 04/2017 - 04/2010
3	Scoliosis 04/2014 - 01/2011
2	Osteoporosis 01/2022 - 01/2022
2	Chondrosarcoma 01/2022 - 10/2019
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 01/2022 - 04/2019
2	Congenital Abnormalities (Deformity) 01/2022 - 12/2009
2	Lymphoma (Lymphomas) 01/2022 - 02/2019
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 01/2022 - 04/2019
2	Gliosis 01/2021 - 01/2018
2	Giant Cell Tumor of Bone 01/2021 - 08/2018
2	Rheumatoid Arthritis 03/2020 - 10/2017
2	Spinal Cord Compression 11/2019 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2006
2	Hemorrhage 01/2018 - 05/2016
2	Pathologic Constriction (Stenosis) 12/2017 - 05/2013
2	Hypertrophy 12/2017 - 01/2017
2	Experimental Arthritis 11/2017 - 12/2016
2	Nocturia 04/2017 - 06/2005
2	Compression Fractures (Compression Fracture) 01/2017 - 06/2014

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2002
9	AntigensIBA 04/2022 - 01/2003
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
7	Interleukin-6 (Interleukin 6)IBA 11/2021 - 08/2013
6	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 06/2022 - 07/2020
5	Diphosphonates (Bisphosphonates)IBA 01/2022 - 06/2003
5	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2012
4	CollagenIBA 01/2022 - 01/2005
4	pazopanib FDA Link 10/2021 - 01/2017
4	EWS-FLI fusion proteinIBA 07/2012 - 04/2003
3	Immune Checkpoint InhibitorsIBA 04/2022 - 10/2020
3	lenvatinibIBA 03/2022 - 10/2021
3	eribulin FDA Link 10/2021 - 01/2018
3	B7-H1 AntigenIBA 01/2021 - 01/2015
3	Prostate-Specific Antigen (Semenogelase)IBA 03/2018 - 08/2012
3	InterleukinsIBA 12/2016 - 02/2014
3	Peptides (Polypeptides)IBA 10/2015 - 01/2013
2	LigandsIBA 04/2022 - 01/2021
2	VaccinesIBA 04/2022 - 05/2016
2	Ibandronic Acid (Boniva)FDA Link 01/2022 - 11/2016
2	ApatitesIBA 01/2022 - 01/2022
2	Muscarinic AntagonistsIBA 01/2022 - 04/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2021 - 11/2017
2	Denosumab FDA Link 01/2021 - 08/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 10/2020
2	Urea (Carbamide)FDA LinkGeneric 07/2020 - 01/2016
2	tocilizumab (atlizumab)FDA Link 03/2020 - 10/2017
2	RNA (Ribonucleic Acid)IBA 10/2019 - 03/2002
2	PlasticsIBA 07/2019 - 09/2013
2	Antiviral Agents (Antivirals)IBA 05/2019 - 01/2019
2	InterferonsIBA 05/2019 - 03/2002
2	Biological ProductsIBA 08/2018 - 01/2003
2	Hypoxia-Inducible Factor 1IBA 01/2018 - 01/2017
2	AntibodiesIBA 01/2018 - 02/2014

Therapy/Procedure

20	Therapeutics 04/2022 - 03/2002
15	Drug Therapy (Chemotherapy) 01/2022 - 03/2013
6	Immunotherapy 06/2022 - 01/2013
6	Radiotherapy 01/2022 - 01/2015
6	Renal Dialysis (Hemodialysis) 02/2019 - 01/2006
4	Heavy Ion Radiotherapy 01/2022 - 01/2017
4	Liver Transplantation 11/2014 - 05/2013
3	Curettage 09/2022 - 08/2018
3	Kyphoplasty 01/2021 - 06/2014
3	Conservative Treatment 11/2019 - 07/2019
2	Blood Transfusion (Blood Transfusions) 08/2021 - 01/2011
2	Operative Time 08/2021 - 02/2019
2	Contraindications 12/2020 - 04/2020
2	Orchiectomy (Orchidectomy) 02/2019 - 03/2010
2	Hepatectomy 01/2019 - 01/2015
2	Prostatectomy (Retropubic Prostatectomy) 05/2018 - 03/2018
2	Splenectomy 01/2018 - 08/2015